CXCL8 (54-72) is a chemokine fragment retaining key residues involved in receptor interaction and structural integrity. Its sequence supports β-sheet and loop conformations characteristic of chemokine cores. Researchers study its role in binding specificity and conformational shifts. Applications include immune-signaling research, motif analysis, and binding-profiling studies.
CXCL8 (54-72) is a synthetic peptide fragment derived from the C-terminal region of the human chemokine CXCL8, also known as interleukin-8 (IL-8). As a biologically active peptide, it encompasses residues 54 to 72 of the native protein, representing a segment involved in the modulation of chemokine-receptor interactions and downstream signaling. Its defined amino acid sequence makes it a valuable tool for dissecting the structure-function relationships within the CXCL8 molecule, supporting research into chemotactic signaling, inflammation, and immune cell recruitment. The availability of this peptide fragment enables researchers to explore the specialized roles of CXCL8 domains in a controlled, reproducible manner, facilitating advanced studies in immunology, cell biology, and peptide biochemistry.
Receptor binding studies: CXCL8 (54-72) is frequently employed to investigate the specific interactions between chemokine fragments and their cognate receptors, such as CXCR1 and CXCR2. By isolating the C-terminal region, researchers can delineate the contributions of this domain to receptor affinity and activation, providing mechanistic insights into how chemokines orchestrate leukocyte migration. Such studies are crucial for mapping receptor-ligand contact sites and for understanding the structural determinants of chemokine signaling.
Peptide structure-function analysis: The defined sequence of this peptide makes it a powerful model for probing the structural motifs responsible for CXCL8's biological activity. Through techniques such as NMR spectroscopy, circular dichroism, or computational modeling, scientists can assess secondary structure formation, conformational stability, and critical residue involvement. These analyses inform the rational design of chemokine analogs or antagonists, supporting efforts in basic research and therapeutic development targeting chemokine-mediated pathways.
Immunological assay development: As a well-characterized peptide fragment, CXCL8 (54-72) is suited for use in immunoassays designed to detect or quantify specific antibody responses against CXCL8 domains. Incorporation of this fragment into ELISA, Western blot, or peptide array platforms allows for the selective measurement of antibodies recognizing the C-terminal epitope, aiding in studies of immune recognition, autoimmunity, or vaccine response profiling.
Peptide-based inhibitor screening: The C-terminal domain of CXCL8 plays a role in receptor activation and downstream signaling, making this fragment a relevant substrate for screening chemical libraries or biologics that may inhibit chemokine-receptor interactions. Utilizing the peptide in high-throughput binding or competition assays enables the identification and characterization of molecules with potential to modulate chemokine-driven processes, supporting drug discovery and chemical biology research.
Cell signaling pathway elucidation: CXCL8 (54-72) can be applied to functional studies exploring the downstream effects of chemokine-receptor engagement. By employing the peptide in cell-based assays, researchers can monitor intracellular signaling cascades, gene expression changes, or chemotactic responses attributable to the C-terminal region. Such investigations provide a deeper understanding of how discrete peptide domains contribute to the overall activity of chemokines in immune cell recruitment and inflammatory response.
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More